Evidence map›Paper›PMID 41043413›Full record

ArticleImmunity2025

Eomesodermin

Ping Zhang, Françoise Haeseleer, Olivia G Waltner, Kate H Gartlan, Shruti S Bhise, Simone A Minnie, Rachael C Adams, Albert C Yeh, Kathleen S Ensbey, Samuel R W Legg and 13 more

Abstract read
In one paragraph

Article in Immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Ping ZhangTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4006, Australia. Electronic address: pzhang@fredhutch.org.
Françoise HaeseleerTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Olivia G WaltnerTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Kate H GartlanQIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4006, Australia.
Shruti S BhiseTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Simone A MinnieTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Rachael C AdamsTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Albert C YehTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Kathleen S EnsbeyTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Samuel R W LeggTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Tomoko SekiguchiTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Erden AtillaTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Nicole S NemychenkovTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Ethan L NelsonTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Tanvi JoshiTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Emily C LiangClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA.
Alexandre V HirayamaClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Kokoro AbeClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Motoko KoyamaTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Andrew D CloustonEnvoi Pathology, Brisbane, QLD 4006, Australia.
Jordan GauthierClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA.
Scott N FurlanTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington, Seattle, WA 98105, USA.
Geoffrey R HillTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA. Electronic address: grhill@fredhutch.org.

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STEPHANIE J LEE · 1985 to 2026
$128.4M
Project 3: Stem Cell Allografts for Lymphoid MalignanciesP01CA078902 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SANDMAIER, BRENDA MARIE · 1999 to 2025
$46.1M
Preventing GVHD by inhibition of alloantigen presentation in the gutR01HL148164 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL, Motoko Koyama · 2019 to 2026
$6.5M
Defining Protective CMV Immunity after TransplantationR01AI175535 · NIAID · FRED HUTCHINSON CANCER CENTER · PI Geoffrey Roger HILL · 2023 to 2026
$3.0M
Propagation of graft vs. host disease through CD4+ T-cell cognate recognition of gastrointestinal microbiotaK08HL167161 · NHLBI · FRED HUTCHINSON CANCER CENTER · PI Albert Chia-Chun Yeh · 2023 to 2026
$650k
NCI NIH HHS P01 CA018029NCI NIH HHS P01 CA078902NHLBI NIH HHS K08 HL167161NHLBI NIH HHS R01 HL148164NIAID NIH HHS R01 AI175535
6 · The paper itself

Abstract

Interleukin 10 (IL-10)-producing CD4

Indexed as

CD4-Positive T-LymphocytesImmunotherapy, AdoptiveT-Box Domain ProteinsT-Lymphocytes, RegulatoryAnimalsAntigens, CD19Bone Marrow TransplantationCell DifferentiationHumansImmunotherapyInterleukin-10MiceReceptors, Chimeric AntigenAntigens, CD19EOMES protein, humanInterleukin-10Receptors, Chimeric AntigenT-Box Domain Proteinsbone marrow transplantationCD4 cytotoxic T lymphocyteschimeric antigen receptor T cellscytokine release syndromeEomesodermingraft-versus-host diseasegraft-versus-leukemiaperforinregulatory T cellstype-1 regulatory T cells

Identifiers

PMID41043413
PMCPMC13570781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.